科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2013/01/16 | 1,384 | 1,390 | 1,364 | 1,376 | -1 | -0.1% | 334,000 |
| 2013/01/15 | 1,344 | 1,382 | 1,344 | 1,377 | +42 | +3.1% | 344,000 |
| 2013/01/11 | 1,352 | 1,361 | 1,333 | 1,335 | -8 | -0.6% | 422,000 |
| 2013/01/10 | 1,343 | 1,352 | 1,322 | 1,343 | ±0 | ±0% | 237,000 |
| 2013/01/09 | 1,324 | 1,349 | 1,324 | 1,343 | +21 | +1.6% | 317,000 |
| 2013/01/08 | 1,301 | 1,331 | 1,301 | 1,322 | +16 | +1.2% | 244,000 |
| 2013/01/07 | 1,315 | 1,320 | 1,303 | 1,306 | -6 | -0.5% | 216,000 |
| 2013/01/04 | 1,287 | 1,313 | 1,287 | 1,312 | +41 | +3.2% | 309,000 |
| 2012/12/28 | 1,279 | 1,285 | 1,266 | 1,271 | -18 | -1.4% | 193,000 |
| 2012/12/27 | 1,293 | 1,299 | 1,284 | 1,289 | -2 | -0.2% | 166,000 |
| 2012/12/26 | 1,287 | 1,298 | 1,282 | 1,291 | +4 | +0.3% | 136,000 |
| 2012/12/25 | 1,299 | 1,303 | 1,286 | 1,287 | -12 | -0.9% | 206,000 |
| 2012/12/21 | 1,308 | 1,310 | 1,297 | 1,299 | -9 | -0.7% | 312,000 |
| 2012/12/20 | 1,296 | 1,315 | 1,295 | 1,308 | +14 | +1.1% | 408,000 |
| 2012/12/19 | 1,289 | 1,295 | 1,281 | 1,294 | +6 | +0.5% | 374,000 |
| 2012/12/18 | 1,279 | 1,295 | 1,274 | 1,288 | +25 | +2% | 347,000 |
| 2012/12/17 | 1,256 | 1,271 | 1,251 | 1,263 | +7 | +0.6% | 228,000 |
| 2012/12/14 | 1,254 | 1,290 | 1,253 | 1,256 | -9 | -0.7% | 272,000 |
| 2012/12/13 | 1,261 | 1,276 | 1,260 | 1,265 | -11 | -0.9% | 280,000 |
| 2012/12/12 | 1,297 | 1,298 | 1,272 | 1,276 | -20 | -1.5% | 211,000 |
| 2012/12/11 | 1,304 | 1,304 | 1,286 | 1,296 | -8 | -0.6% | 109,000 |
| 2012/12/10 | 1,310 | 1,317 | 1,294 | 1,304 | +10 | +0.8% | 211,000 |
| 2012/12/07 | 1,303 | 1,303 | 1,293 | 1,294 | -9 | -0.7% | 158,000 |
| 2012/12/06 | 1,298 | 1,308 | 1,294 | 1,303 | +14 | +1.1% | 220,000 |
| 2012/12/05 | 1,299 | 1,303 | 1,288 | 1,289 | -9 | -0.7% | 285,000 |
| 2012/12/04 | 1,300 | 1,306 | 1,291 | 1,298 | +5 | +0.4% | 211,000 |
| 2012/12/03 | 1,287 | 1,306 | 1,287 | 1,293 | +2 | +0.2% | 222,000 |
| 2012/11/30 | 1,309 | 1,318 | 1,287 | 1,291 | -11 | -0.8% | 310,000 |
| 2012/11/29 | 1,282 | 1,307 | 1,279 | 1,302 | +18 | +1.4% | 310,000 |
| 2012/11/28 | 1,256 | 1,290 | 1,256 | 1,284 | +23 | +1.8% | 270,000 |
| 2012/11/27 | 1,243 | 1,266 | 1,243 | 1,261 | +8 | +0.6% | 342,000 |
| 2012/11/26 | 1,251 | 1,266 | 1,243 | 1,253 | -5 | -0.4% | 230,000 |
| 2012/11/22 | 1,275 | 1,275 | 1,253 | 1,258 | -11 | -0.9% | 280,000 |
| 2012/11/21 | 1,282 | 1,284 | 1,268 | 1,269 | -20 | -1.6% | 279,000 |
| 2012/11/20 | 1,298 | 1,298 | 1,281 | 1,289 | -4 | -0.3% | 191,000 |
| 2012/11/19 | 1,279 | 1,294 | 1,278 | 1,293 | +19 | +1.5% | 133,000 |
| 2012/11/16 | 1,275 | 1,277 | 1,261 | 1,274 | +1 | +0.1% | 205,000 |
| 2012/11/15 | 1,273 | 1,288 | 1,270 | 1,273 | -24 | -1.9% | 209,000 |
| 2012/11/14 | 1,265 | 1,299 | 1,255 | 1,297 | +32 | +2.5% | 263,000 |
| 2012/11/13 | 1,250 | 1,266 | 1,248 | 1,265 | +12 | +1% | 160,000 |
| 2012/11/12 | 1,261 | 1,269 | 1,251 | 1,253 | -19 | -1.5% | 162,000 |
| 2012/11/09 | 1,279 | 1,283 | 1,271 | 1,272 | -16 | -1.2% | 98,000 |
| 2012/11/08 | 1,291 | 1,300 | 1,280 | 1,288 | -7 | -0.5% | 258,000 |
| 2012/11/07 | 1,285 | 1,305 | 1,282 | 1,295 | +19 | +1.5% | 366,000 |
| 2012/11/06 | 1,248 | 1,278 | 1,237 | 1,276 | +28 | +2.2% | 198,000 |
| 2012/11/05 | 1,251 | 1,257 | 1,246 | 1,248 | -10 | -0.8% | 135,000 |
| 2012/11/02 | 1,241 | 1,259 | 1,241 | 1,258 | +17 | +1.4% | 109,000 |
| 2012/11/01 | 1,233 | 1,249 | 1,228 | 1,241 | +4 | +0.3% | 263,000 |
| 2012/10/31 | 1,229 | 1,246 | 1,215 | 1,237 | +4 | +0.3% | 187,000 |
| 2012/10/30 | 1,235 | 1,246 | 1,233 | 1,233 | -7 | -0.6% | 160,000 |
3001～
3050
件表示中 / 3686件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 407,000円 | +30.5% | +111.0% | 4.67% | 11.47倍 | 0.99倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 日本新薬 | 363,100円 | +7.9% | +8.9% | 3.42% | 7.77倍 | 1.05倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ペプチド | 194,200円 | +5.0% | +1.5% | 0.00% | 16.67倍 | 4.43倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 384,000円 | +14.5% | -2.3% | 2.34% | 14.05倍 | 0.75倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| サンバイオ | 195,500円 | - | - | 0.00% | - | 90.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
